AU3864899A - Treatment of generalized anxiety disorder with paroxetine - Google Patents
Treatment of generalized anxiety disorder with paroxetine Download PDFInfo
- Publication number
- AU3864899A AU3864899A AU38648/99A AU3864899A AU3864899A AU 3864899 A AU3864899 A AU 3864899A AU 38648/99 A AU38648/99 A AU 38648/99A AU 3864899 A AU3864899 A AU 3864899A AU 3864899 A AU3864899 A AU 3864899A
- Authority
- AU
- Australia
- Prior art keywords
- paroxetine
- treatment
- anxiety disorder
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9808479 | 1998-04-22 | ||
| GBGB9808479.1A GB9808479D0 (en) | 1998-04-22 | 1998-04-22 | Method of treatment |
| PCT/US1999/008786 WO1999053919A1 (en) | 1998-04-22 | 1999-04-22 | Treatment of generalized anxiety disorder with paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3864899A true AU3864899A (en) | 1999-11-08 |
Family
ID=10830715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU38648/99A Abandoned AU3864899A (en) | 1998-04-22 | 1999-04-22 | Treatment of generalized anxiety disorder with paroxetine |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1073437A4 (sk) |
| JP (1) | JP2002512189A (sk) |
| KR (1) | KR20010034817A (sk) |
| CN (1) | CN1298301A (sk) |
| AP (1) | AP2000001959A0 (sk) |
| AU (1) | AU3864899A (sk) |
| BG (1) | BG104939A (sk) |
| BR (1) | BR9909791A (sk) |
| CA (1) | CA2328896A1 (sk) |
| CZ (1) | CZ20003885A3 (sk) |
| EA (1) | EA200001088A1 (sk) |
| GB (1) | GB9808479D0 (sk) |
| HU (1) | HUP0101350A3 (sk) |
| ID (1) | ID27546A (sk) |
| IL (1) | IL139167A0 (sk) |
| NO (1) | NO20005286L (sk) |
| PL (1) | PL343494A1 (sk) |
| SK (1) | SK15672000A3 (sk) |
| TR (1) | TR200003082T2 (sk) |
| WO (1) | WO1999053919A1 (sk) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2297550B (en) * | 1995-02-06 | 1997-04-09 | Smithkline Beecham Plc | Paroxetine hydrochloride anhydrate substantially free of bound organic solvent |
| GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
-
1998
- 1998-04-22 GB GBGB9808479.1A patent/GB9808479D0/en not_active Ceased
-
1999
- 1999-04-22 SK SK1567-2000A patent/SK15672000A3/sk unknown
- 1999-04-22 AP APAP/P/2000/001959A patent/AP2000001959A0/en unknown
- 1999-04-22 ID IDW20002124A patent/ID27546A/id unknown
- 1999-04-22 AU AU38648/99A patent/AU3864899A/en not_active Abandoned
- 1999-04-22 HU HU0101350A patent/HUP0101350A3/hu unknown
- 1999-04-22 IL IL13916799A patent/IL139167A0/xx unknown
- 1999-04-22 EA EA200001088A patent/EA200001088A1/ru unknown
- 1999-04-22 CZ CZ20003885A patent/CZ20003885A3/cs unknown
- 1999-04-22 TR TR2000/03082T patent/TR200003082T2/xx unknown
- 1999-04-22 CN CN99805328A patent/CN1298301A/zh active Pending
- 1999-04-22 WO PCT/US1999/008786 patent/WO1999053919A1/en not_active Application Discontinuation
- 1999-04-22 JP JP2000544323A patent/JP2002512189A/ja not_active Withdrawn
- 1999-04-22 BR BR9909791-5A patent/BR9909791A/pt not_active IP Right Cessation
- 1999-04-22 CA CA002328896A patent/CA2328896A1/en not_active Abandoned
- 1999-04-22 EP EP99921431A patent/EP1073437A4/en not_active Withdrawn
- 1999-04-22 KR KR1020007011729A patent/KR20010034817A/ko not_active Application Discontinuation
- 1999-04-22 PL PL99343494A patent/PL343494A1/xx not_active Application Discontinuation
-
2000
- 2000-10-20 NO NO20005286A patent/NO20005286L/no not_active Application Discontinuation
- 2000-11-13 BG BG104939A patent/BG104939A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005286D0 (no) | 2000-10-20 |
| SK15672000A3 (sk) | 2001-04-09 |
| KR20010034817A (ko) | 2001-04-25 |
| WO1999053919A1 (en) | 1999-10-28 |
| EA200001088A1 (ru) | 2001-04-23 |
| AP2000001959A0 (en) | 2000-12-31 |
| BG104939A (bg) | 2001-09-28 |
| CZ20003885A3 (cs) | 2001-09-12 |
| BR9909791A (pt) | 2000-12-26 |
| NO20005286L (no) | 2000-12-20 |
| GB9808479D0 (en) | 1998-06-17 |
| CA2328896A1 (en) | 1999-10-28 |
| TR200003082T2 (tr) | 2001-01-22 |
| EP1073437A4 (en) | 2003-04-16 |
| EP1073437A1 (en) | 2001-02-07 |
| JP2002512189A (ja) | 2002-04-23 |
| HUP0101350A2 (hu) | 2002-05-29 |
| IL139167A0 (en) | 2001-11-25 |
| HUP0101350A3 (en) | 2002-06-28 |
| PL343494A1 (en) | 2001-08-27 |
| CN1298301A (zh) | 2001-06-06 |
| ID27546A (id) | 2001-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5371092A (en) | Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia | |
| US4804669A (en) | Treatment of pain with a piperidine | |
| US6121291A (en) | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder | |
| AP460A (en) | Naphthyl derivative for treatment method. | |
| AU739466B2 (en) | Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (SSRI) | |
| JPH06511231A (ja) | ２−（ピロリジニル−１−メチル）−ピペリジン誘導体およびκ受容体アゴニストとしてのその使用 | |
| WO2004091615A1 (en) | Combinations of paroxetine and 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-((8as)-6-oxo-hexahydro-pyrrolo[1,2-a]-pyrazin-2-yl)-piperidine-1-carboxylic acid[1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide for treatment of depression/anxiety | |
| AU3864899A (en) | Treatment of generalized anxiety disorder with paroxetine | |
| MXPA00010343A (en) | Treatment of generalized anxiety disorder with paroxetine | |
| EP0372694A2 (en) | Azacyclic derivatives with diuretic activity | |
| KR20010071893A (ko) | 치료 방법 | |
| WO1992008451A1 (en) | Use of nabumetone for treatment of cancer pain | |
| WO1992008452A1 (en) | Use of nabumetone for the treatment of myofascial pain syndrome | |
| MXPA00000522A (en) | Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) | |
| CZ200085A3 (cs) | Léčivo proti srdečním poruchám a farmaceutický prostředek s obsahem SSRI |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |